Fig. 1.
Proposed algorithm for the use of Pegvisomant in acromegaly patients partially or not responder to SRLs. SRL somatostatin receptor ligands, PEG Pegvisomant, RT radiation therapy, TG tumor growth, DA dopamine agonists
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.